Interim analysis to be conducted under an FDA- and EMA-agreed protocol. Ramat Gan, Israel, July 06, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: C ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results